Nexus Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Nexus de 15.8% y 9.2% por año respectivamente. Se prevé que el BPA crezca en un 15.9% al año. Se espera que la rentabilidad financiera sea de 12% en 3 años.

Información clave

15.8%

Tasa de crecimiento de los beneficios

15.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare Services	28.7%
Tasa de crecimiento de los ingresos	9.2%
Rentabilidad financiera futura	12.0%
Cobertura de analistas	Good
Última actualización	12 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Mar 08

Recent updates

Should You Investigate Nexus AG (ETR:NXU) At €52.80?

Apr 20

Nexus AG (ETR:NXU) Shares Could Be 27% Below Their Intrinsic Value Estimate

Mar 28

Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Mar 08

Nexus AG's (ETR:NXU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 04

Calculating The Intrinsic Value Of Nexus AG (ETR:NXU)

Jan 18

We're Watching These Trends At Nexus (ETR:NXU)

Dec 29

Introducing Nexus (ETR:NXU), The Stock That Zoomed 189% In The Last Five Years

Nov 30

Is Nexus AG's (ETR:NXU) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jun 30

Previsiones de crecimiento de beneficios e ingresos

XTRA:NXU - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	330	41	45	60	7
12/31/2025	300	36	41	55	7
12/31/2024	272	30	34	47	7
12/31/2023	245	24	21	30	N/A
9/30/2023	233	24	23	32	N/A
6/30/2023	224	21	21	30	N/A
3/31/2023	217	21	22	28	N/A
12/31/2022	212	19	28	34	N/A
9/30/2022	204	20	32	38	N/A
6/30/2022	200	19	28	34	N/A
3/31/2022	196	18	33	39	N/A
12/31/2021	191	17	26	31	N/A
9/30/2021	188	17	22	29	N/A
6/30/2021	179	16	26	32	N/A
3/31/2021	171	16	26	31	N/A
12/31/2020	166	15	26	31	N/A
9/30/2020	160	13	21	27	N/A
6/30/2020	159	13	25	31	N/A
3/31/2020	155	11	13	19	N/A
12/31/2019	151	11	19	25	N/A
9/30/2019	151	10	22	25	N/A
6/30/2019	145	10	17	22	N/A
3/31/2019	144	11	23	29	N/A
12/31/2018	141	11	13	20	N/A
9/30/2018	133	11	14	22	N/A
6/30/2018	130	10	13	22	N/A
3/31/2018	127	10	13	21	N/A
12/31/2017	124	10	14	22	N/A
9/30/2017	121	9	N/A	21	N/A
6/30/2017	119	9	N/A	20	N/A
3/31/2017	115	8	N/A	21	N/A
12/31/2016	112	8	N/A	17	N/A
9/30/2016	110	8	N/A	20	N/A
6/30/2016	108	7	N/A	22	N/A
3/31/2016	106	8	N/A	20	N/A
12/31/2015	103	8	N/A	18	N/A
9/30/2015	99	9	N/A	18	N/A
6/30/2015	94	9	N/A	17	N/A
3/31/2015	89	8	N/A	15	N/A
12/31/2014	85	8	N/A	12	N/A
9/30/2014	82	7	N/A	11	N/A
6/30/2014	81	8	N/A	12	N/A
3/31/2014	80	7	N/A	14	N/A
12/31/2013	78	7	N/A	11	N/A
9/30/2013	75	7	N/A	8	N/A
6/30/2013	72	7	N/A	6	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (15.8% al año) de NXU es superior a la tasa de ahorro (0.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (15.8% al año) de NXU crezcan más rápidamente que el mercado German (14% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de NXU crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (9.2% al año) de NXU crezcan más rápidamente que los del mercado German (5.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 9.2% al año) de NXU crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de NXU sea baja dentro de 3 años (12%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Nexus Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Price target decreased to €64.17

Price target decreased to €70.00

Price target increased to €76.00

Price target increased to €68.80

Price target raised to €49.83

Recent updates

Should You Investigate Nexus AG (ETR:NXU) At €52.80?

Dividend increased to €0.22

Nexus AG (ETR:NXU) Shares Could Be 27% Below Their Intrinsic Value Estimate

Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital At Nexus (ETR:NXU) Have Stalled

Why Nexus AG (ETR:NXU) Could Be Worth Watching

Nexus AG to Report Q1, 2024 Results on May 14, 2024

Third quarter 2023 earnings released: EPS: €0.42 (vs €0.28 in 3Q 2022)

Is There An Opportunity With Nexus AG's (ETR:NXU) 23% Undervaluation?

Now 20% undervalued after recent price drop

Upcoming dividend of €0.21 per share at 0.4% yield

Returns On Capital At Nexus (ETR:NXU) Have Stalled

Is Nexus AG (ETR:NXU) Potentially Undervalued?

Full year 2022 earnings released: EPS: €1.21 (vs €1.09 in FY 2021)

Here's What To Make Of Nexus' (ETR:NXU) Decelerating Rates Of Return

Nexus AG to Report Q3, 2023 Results on Nov 07, 2023

Nexus AG to Report First Half, 2023 Results on Aug 15, 2023

Nexus AG to Report Fiscal Year 2022 Results on Mar 07, 2023

Should You Think About Buying Nexus AG (ETR:NXU) Now?

Investor sentiment improved over the past week

Price target decreased to €64.17

Second quarter 2022 earnings released: EPS: €0.31 (vs €0.24 in 2Q 2021)

Nexus (ETR:NXU) Is Looking To Continue Growing Its Returns On Capital

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to €70.00

Upcoming dividend of €0.20 per share

Should You Think About Buying Nexus AG (ETR:NXU) Now?

Full year 2021 earnings: Revenues in line with analyst expectations

Nexus AG Proposes to Pay A Dividend

Nexus (ETR:NXU) Has More To Do To Multiply In Value Going Forward

Third quarter 2021 earnings released: EPS €0.22 (vs €0.17 in 3Q 2020)

Price target increased to €76.00

Price target increased to €68.80

Second quarter 2021 earnings released: EPS €0.24 (vs €0.20 in 2Q 2020)

Estimating The Intrinsic Value Of Nexus AG (ETR:NXU)

Returns On Capital At Nexus (ETR:NXU) Have Hit The Brakes

Nexus AG (XTRA:NXU) acquired Dc-Systeme Informatik Gmbh.

First quarter 2021 earnings released: EPS €0.23 (vs €0.19 in 1Q 2020)

Upcoming dividend of €0.19 per share

Estimating The Intrinsic Value Of Nexus AG (ETR:NXU)

Nexus (ETR:NXU) Hasn't Managed To Accelerate Its Returns

Revenue and earnings beat expectations

Shareholders Are Thrilled That The Nexus (ETR:NXU) Share Price Increased 209%

Full year 2020 earnings released: EPS €0.95 (vs €0.69 in FY 2019)

Do Institutions Own Nexus AG (ETR:NXU) Shares?

Nexus AG's (ETR:NXU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Calculating The Intrinsic Value Of Nexus AG (ETR:NXU)

New 90-day high: €55.00

We're Watching These Trends At Nexus (ETR:NXU)

Introducing Nexus (ETR:NXU), The Stock That Zoomed 189% In The Last Five Years

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: EPS €0.17

Price target raised to €49.83

Nexus AG to Report First Half, 2021 Results on Aug 10, 2021

New 90-day high: €51.60

Nexus AG (XTRA:NXU) acquired approximately 93% stake in RVC Medical IT from Main Capital Partners B.V.

New 90-day high - €44.80

New 90-day high - €44.20

Price target raised to €39.67

New 90-day high - €42.70

Is Nexus AG's (ETR:NXU) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento